Schedule 13G ownership disclosure
OUTLOOK THERAPEUTICS INC
Common Stock, par value $0.01 per share · CUSIP: 69012T305
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sphera Funds Management Ltd.
Shares: 3,153,856 · Class: 4.69%
- Sphera Global Healthcare GP Ltd.
Shares: 3,153,856 · Class: 4.69%
- Sphera Global Healthcare Management LP.
Shares: 3,153,856 · Class: 4.69%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-26-000311
- Form type
- SCHEDULE 13G/A
- Filer
- Outlook Therapeutics, Inc.
- CIK
- CIK 1649989
- Filed
- Feb 05, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership